1. Open‐label study of etanercept treatment in patients with moderate‐to‐severe plaque psoriasis who lost a satisfactory response to adalimumab. (19th July 2017) Authors: Bagel, J.; Tyring, S.; Rice, K.C.; Collier, D.H.; Kricorian, G.; Chung, J.; Iles, J.; Stolshek, B.S.; Kaliyaperumal, A.; Papp, K.A. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Open‐label study of etanercept treatment in patients with moderate‐to‐severe plaque psoriasis who lost a satisfactory response to adalimumab. (1st August 2017) Authors: Bagel, J.; Tyring, S.; Rice, K.C.; Collier, D.H.; Kricorian, G.; Chung, J.; Iles, J.; Stolshek, B.S.; Kaliyaperumal, A.; Papp, K.A. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗